In patients with HIV and heart failure (HF), protease inhibitor-based regimens are associated with dyslipidemia, diabetes, coronary artery disease (CAD), a lower left ventricular ejection fraction, and a higher pulmonary artery systolic pressure (PASP). The retrospective single-center study included all 394 antiretroviral therapy-treated persons with human immunodeficiency virus (PHIV) who were hospitalized with HF in 2011, and stratified by PI and non-PI (NPI). The primary outcome was cardiovascular (CV) mortality and secondary outcome was 30-day HF readmission rate. Researchers found:
- Of the 394 PHIV with HF (mean age 60 ±9.5 years, 47% female), 145 (37%) were prescribed a PI, while 249 (63%) were prescribed NPI regimens.
- PHIV who were receiving a PI had higher rates of hyperlipidemia, diabetes mellitus, and CAD; higher PASP; and lower left ventricular ejection fraction.
- In follow-up, PI was associated with increased CV mortality and 30-day HF readmission.
- Overall, PIs were associated with a 2-fold increased risk of CV mortality.
Alvi RM, Neilan AM, Tariq N, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure. J Am Coll Cardiol. 2018;72(5):518-530. doi:10.1016/j.jacc.2018.04.083.
This Week's Must Reads
Long-Term LDL-C and CV Mortality Risk, Circulation; ePub 2018 Aug 16; Abdullah, et al
Breastfeeding and Risk of Stroke in Postmenopausal Women, J Am Heart Assoc; ePub 2018 Aug 22; Jacobson, et al
Psychosocial Stressors & AF in Older Women, Am J Cardiol; ePub 2018 Aug 17; Westcott, et al
Does Dietary Diversity Promote a Healthy Weight?, Circulation; ePub 2018 Aug 9; de Oliveira, et al
Dementia Progression in Men and Women with AF, Am J Cardiol; ePub 2018 Aug 3; Golive, et al
Must Reads in Heart Failure
PIs and CV Outcomes in Patients with HIV and HF, J Am Coll Cardiol; 2018 Jul; Alvi, Neilan, et al
Exercise Training Workloads in Patients with HF, Am Heart J; ePub 2018 Jul 10; Keteyian, et al
Renal Function & Exercise Training in HF Patients, Am J Cardiol; ePub 2018 Jun 23; Ambrosy, et al
Glucose-Lowering Medication Use in T2D and HF, Am Heart J; ePub 2018 Jun 15; Arnold, et al
Care for IHD and CHF Varies in VA Health System, JAMA Cardiol; ePub 2018 May 16; Groeneveld, et al